Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
Westover, D, Zugazagoitia, J, Cho, B C, Lovly, C M, Paz-Ares, L
Published in Annals of oncology (01.01.2018)
Published in Annals of oncology (01.01.2018)
Get full text
Journal Article
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Garrido, P., Conde, E., de Castro, J., Gómez-Román, J. J., Felip, E., Pijuan, L., Isla, D., Sanz, J., Paz-Ares, L., López-Ríos, F.
Published in Clinical & translational oncology (01.07.2020)
Published in Clinical & translational oncology (01.07.2020)
Get full text
Journal Article
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
PORTA, R, SANCHEZ-TORRES, J. M, CATOT, S, ISLA, D, PRADAS, A, GURPIDE, A, DE CASTRO, J, POLO, E, PUIG, T, TARON, M, COLOMER, R, ROSELL, R, PAZ-ARES, L, MASSUTI, B, REGUART, N, MAYO, C, LIANES, P, QUERALT, C, GUILLEM, V, SALINAS, P
Published in The European respiratory journal (01.03.2011)
Published in The European respiratory journal (01.03.2011)
Get full text
Journal Article
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
Bellmunt, J, Paz-Ares, L, Cuello, M, Cecere, FL, Albiol, S, Guillem, V, Gallardo, E, Carles, J, Mendez, P, de la Cruz, JJ, Taron, M, Rosell, R, Baselga, J
Published in Annals of oncology (01.03.2007)
Published in Annals of oncology (01.03.2007)
Get full text
Journal Article
A potential therapeutic strategy based on acute oxidative stress induction for wild-type NRF2/KEAP1 lung squamous cell carcinoma
Sánchez-Ortega, M., Garrido, A., Cirauqui, C., Sanz-Gonzalez, L., Hernández, M.C., González-García, A., Obregon, K., Ferrer, I., Paz-Ares, L., Carrera, A.C.
Published in Redox biology (01.09.2024)
Published in Redox biology (01.09.2024)
Get full text
Journal Article
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts
Früh, M., Panje, C.M., Reck, M., Blackhall, F., Califano, R., Cappuzzo, F., Besse, B., Novello, S., Garrido, P., Felip, E., O'Brien, M., Paz Ares, L., de Marinis, F., Westeel, V., De Ruysscher, D., Putora, P.M.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Get full text
Journal Article
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform
Morfouace, M., Novello, S., Stevovic, A., Dooms, C., Janžič, U., Berghmans, T., Dziadziuszko, R., Gorlia, T., Felip, E., Paz-Ares, L., Mazieres, J., O’Brien, M., Bironzo, P., Vansteenkiste, J., Lacroix, L., Dingemans, A. C., Golfinopoulos, V., Besse, B.
Published in Scientific reports (18.05.2022)
Published in Scientific reports (18.05.2022)
Get full text
Journal Article
Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients
Cedrés, S., Ponce-Aix, S., Iranzo, P., Callejo, A., Pardo, N., Navarro, A., Martinez-Marti, A., Gómez-Abecia, S., Zucchiatti, A. C., Sansano, I., Enguita, A. B., Miquel, J. M., Viaplana, C., Dienstmann, R., Paz-Ares, L., Felip, E.
Published in Clinical & translational oncology (01.08.2020)
Published in Clinical & translational oncology (01.08.2020)
Get full text
Journal Article
Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials
Scagliotti, G.V, Gridelli, C, de Marinis, F, Thomas, M, Dediu, M, Pujol, J.-L, Manegold, C, San Antonio, B, Peterson, P.M, John, W, Chouaki, N, Visseren-Grul, C, Paz-Ares, L.G
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2014)
Get full text
Journal Article
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
Gualberto, A, Hixon, M L, Karp, D D, Li, D, Green, S, Dolled-Filhart, M, Paz-Ares, L G, Novello, S, Blakely, J, Langer, C J, Pollak, M N
Published in British journal of cancer (04.01.2011)
Published in British journal of cancer (04.01.2011)
Get full text
Journal Article
Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Felip, E., Concha, Á., de Castro, J., Gómez-Román, J., Garrido, P., Ramírez, J., Isla, D., Sanz, J., Paz-Ares, L., López-Ríos, F.
Published in Clinical & translational oncology (01.02.2015)
Published in Clinical & translational oncology (01.02.2015)
Get full text
Journal Article
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
Paz-Ares, L., Spira, A., Raben, D., Planchard, D., Cho, B.C., Özgüroğlu, M., Daniel, D., Villegas, A., Vicente, D., Hui, R., Murakami, S., Spigel, D., Senan, S., Langer, C.J., Perez, B.A., Boothman, A-M., Broadhurst, H., Wadsworth, C., Dennis, P.A., Antonia, S.J., Faivre-Finn, C.
Published in Annals of oncology (01.06.2020)
Published in Annals of oncology (01.06.2020)
Get full text
Journal Article
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
Paz-Ares, L., Tan, E.-H., O’Byrne, K., Zhang, L., Hirsh, V., Boyer, M., Yang, J.C.-H., Mok, T., Lee, K.H., Lu, S., Shi, Y., Lee, D.H., Laskin, J., Kim, D.-W., Laurie, S.A., Kölbeck, K., Fan, J., Dodd, N., Märten, A., Park, K.
Published in Annals of oncology (01.02.2017)
Published in Annals of oncology (01.02.2017)
Get full text
Journal Article
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
Passaro, A., Leighl, N., Blackhall, F., Popat, S., Kerr, K., Ahn, M.J., Arcila, M.E., Arrieta, O., Planchard, D., de Marinis, F., Dingemans, A.M., Dziadziuszko, R., Faivre-Finn, C., Feldman, J., Felip, E., Curigliano, G., Herbst, R., Jänne, P.A., John, T., Mitsudomi, T., Mok, T., Normanno, N., Paz-Ares, L., Ramalingam, S., Sequist, L., Vansteenkiste, J., Wistuba, I.I., Wolf, J., Wu, Y.L., Yang, S.R., Yang, J.C.H., Yatabe, Y., Pentheroudakis, G., Peters, S.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
Griesinger, F., Curigliano, G., Thomas, M., Subbiah, V., Baik, C.S., Tan, D.S.W., Lee, D.H., Misch, D., Garralda, E., Kim, D.-W., van der Wekken, A.J., Gainor, J.F., Paz-Ares, L., Liu, S.V., Kalemkerian, G.P., Houvras, Y., Bowles, D.W., Mansfield, A.S., Lin, J.J., Smoljanovic, V., Rahman, A., Kong, S., Zalutskaya, A., Louie-Gao, M., Boral, A.L., Mazières, J.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN
Paz-Ares, L., Chen, Y., Reinmuth, N., Hotta, K., Trukhin, D., Statsenko, G., Hochmair, M.J., Özgüroğlu, M., Ji, J.H., Garassino, M.C., Voitko, O., Poltoratskiy, A., Musso, E., Havel, L., Bondarenko, I., Losonczy, G., Conev, N., Mann, H., Dalvi, T.B., Jiang, H., Goldman, J.W.
Published in ESMO open (01.04.2022)
Published in ESMO open (01.04.2022)
Get full text
Journal Article
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
Arnold, D., Fuchs, C.S., Tabernero, J., Ohtsu, A., Zhu, A.X., Garon, E.B., Mackey, J.R., Paz-Ares, L., Baron, A.D., Okusaka, T., Yoshino, T., Yoon, H.H., Das, M., Ferry, D., Zhang, Y., Lin, Y., Binder, P., Sashegyi, A., Chau, I.
Published in Annals of oncology (01.12.2017)
Published in Annals of oncology (01.12.2017)
Get full text
Journal Article
Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium
BELLMUNT, J, GUILLEM, V, BASTUS, R, CLIMENT, M. A, DE LA CRUZ, J. J, ALBANELL, J, BANUS, J. M, GALLARDO, E, DIAZ-RUBIO, E, CORTES-FUNES, H, BASELGA, J, PAZ-ARES, L, GONZALEZ-LARRIBA, J. L, CARIES, J, BATISTE-ALENTORN, E, SAENZ, A, LOPEZ-BREA, M, FONT, A, NOGUE, M
Published in Journal of clinical oncology (18.09.2000)
Published in Journal of clinical oncology (18.09.2000)
Get full text
Journal Article
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
Besse, B., Adjei, A., Baas, P., Meldgaard, P., Nicolson, M., Paz-Ares, L., Reck, M., Smit, E.F., Syrigos, K., Stahel, R., Felip, E., Peters, S., Stahel, Rolf, Felip, Enriqueta, Peters, Solange, Kerr, Keith, Besse, Benjamin, Vansteenkiste, Johan, Eberhardt, Wilfried, Edelman, Martin, Mok, Tony, O'Byrne, Ken, Novello, Silvia, Bubendorf, Lukas, Marchetti, Antonio, Baas, Paul, Reck, Martin, Syrigos, Konstantinos, Paz-Ares, Luis, Smit, Egbert F., Meldgaard, Peter, Adjei, Alex, Nicolson, Marianne, Crinò, Lucio, Van Schil, Paul, Senan, Suresh, Faivre-Finn, Corinne, Rocco, Gaetano, Veronesi, Giulia, Douillard, Jean-Yves, Lim, Eric, Dooms, Christophe, Weder, Walter, De Ruysscher, Dirk, Le Pechoux, Cecile, De Leyn, Paul, Westeel, Virginie
Published in Annals of oncology (01.08.2014)
Published in Annals of oncology (01.08.2014)
Get full text
Journal Article
Conference Proceeding